Epoprostenol Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-642

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Epoprostenol (NDC 68083-642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epoprostenol-spl-carton-label-0-5mg (Epoprostenol Spl Carton Label 0 5mg)

Description: This is a product information sheet for Epoprostenol for Injection manufactured by Gland Pharma Limited in Hyderabad, India. The product comes in single-dose vials and is intended for intravenous infusion only. Each vial contains epoprostenol sodium, sucrose, glycine, and sodium hydroxide to adjust pH. The dosage and storage instructions, as well as details on prescribing information and stability, are provided. The product is stored at 20°C to 25°C with excursions permitted to 15° to 30°C and should be protected from light. Dilution instructions and room temperature storage stability information are also included.*

FDA Label Image

Epoprostenol-spl-carton-label-1-5mg (Epoprostenol Spl Carton Label 1 5mg)

This is a label for Epoprostenol for injection, a medication used for intravenous infusion. Each vial contains epoprostenol sodium, sucrose, glycine, and sodium hydroxide. The dosage and storage instructions are provided on the label. It is manufactured by Gland Pharma Limited in India.*

FDA Label Image

Epoprostenol-spl-container-label-0-5mg (Epoprostenol Spl Container Label 0 5mg)

This text seems to be a pharmaceutical label for a medication that needs to be reconstituted before use. The manufacturer is Gland Pharma Limited from Hyderabad, India. The product is intended for intravenous infusion only and should be stored at controlled room temperature. The medication is in a sterile, lyophilized form in a single-dose vial. After reconstitution, the correct dose should be withdrawn and diluted to the final concentration in a reservoir. Unused portions should be discarded.*

FDA Label Image

Epoprostenol-spl-container-label-1-5mg (Epoprostenol Spl Container Label 1 5mg)

This is a description of Epoprostenol for Injection, a sterile, lyophilized product packaged in single-dose vials for intravenous infusion only. The instructions indicate to discard any unused portion after reconstitution, store the product at 20°C to 25°C, protect it from light, and dilute to the final concentration in a reservoir. The manufacturing information reveals that it is produced by Gland Pharma Limited in Hyderabad, India. The provided NDC code for this product is 68083-642-01.*

FDA Label Image

Epoprostenol-spl-structure (Epoprostenol Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.